Peter Maag - 10 May 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Signature
/s/ Peter Maag
Issuer symbol
CDNA
Transactions as of
10 May 2021
Net transactions value
-$7,615,423
Form type
4
Filing time
12 May 2021, 18:53:23 UTC
Next filing
27 May 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $19,547 +3,313 +0.81% $5.90 412,757 10 May 2021 Direct
transaction CDNA Common Stock Options Exercise $51,161 +8,108 +2% $6.31 420,865 10 May 2021 Direct
transaction CDNA Common Stock Options Exercise $182,033 +14,872 +3.5% $12.24 435,737 10 May 2021 Direct
transaction CDNA Common Stock Sale $686,786 -10,284 -2.4% $66.78 425,453 10 May 2021 Direct F1
transaction CDNA Common Stock Sale $21,750 -317 -0.07% $68.61 425,136 10 May 2021 Direct F2
transaction CDNA Common Stock Sale $1,104,088 -15,692 -3.7% $70.36 409,444 10 May 2021 Direct F3
transaction CDNA Common Stock Options Exercise $1,066,447 +87,128 +21% $12.24 496,572 11 May 2021 Direct
transaction CDNA Common Stock Sale $1,961,133 -29,792 -6% $65.83 466,780 11 May 2021 Direct F4
transaction CDNA Common Stock Sale $1,923,123 -28,986 -6.2% $66.35 437,794 11 May 2021 Direct F5
transaction CDNA Common Stock Sale $1,483,827 -21,985 -5% $67.49 415,809 11 May 2021 Direct F6
transaction CDNA Common Stock Sale $434,717 -6,365 -1.5% $68.30 409,444 11 May 2021 Direct F7
holding CDNA Common Stock 1,000 10 May 2021 As UTMA custodian for minor child F8
holding CDNA Common Stock 1,000 10 May 2021 As UTMA custodian for minor child F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Options Exercise $19,547 -3,313 -16% $5.90 17,312 10 May 2021 Common Stock 3,313 $5.90 Direct F9
transaction CDNA Employee Stock Option (right to buy) Options Exercise $51,161 -8,108 -40% $6.31 12,032 10 May 2021 Common Stock 8,108 $6.31 Direct F10
transaction CDNA Employee Stock Option (right to buy) Options Exercise $182,033 -14,872 -10% $12.24 127,753 10 May 2021 Common Stock 14,872 $12.24 Direct F11
transaction CDNA Employee Stock Option (right to buy) Options Exercise $1,066,447 -87,128 -68% $12.24 40,625 11 May 2021 Common Stock 87,128 $12.24 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.455 to $67.28, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.02 to $68.85, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.67 to $70.515, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $66.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.005 to $67.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.01 to $68.01, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.015 to $68.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F8 Shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F9 25% of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option shall vest monthly thereafter.
F10 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter.
F11 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter.